Tag: bladder cancer
-
Zantac Recall In April 2020 Comes 7 Months After The Zantac FDA Warning In September 2019
Level Of Chemical NDMA In Zantac Pills Can Cause Cancers: Pancreatic, Stomach, Colon, Rectal, Bladder, Kidney (Posted by Tom Lamb at DrugInjuryWatch.com) On April 1, 2020, the FDA announced that it was…
-
Zantac FDA Warning In September 2019 Leads To Lawsuits For Patients Diagnosed With Cancer
Cases Involve Stomach, Colon, Rectal, Bladder, Kidney, And Pancreatic Cancers Diagnosed After Taking Zantac (Posted by Tom Lamb at DrugInjuryWatch.com) Zantac cancer lawsuits are being filed for patients diagnosed with certain types…
-
Medical Researchers Continue To Study Bladder Cancer As A Possible Side Effect Of Jardiance
New Analysis Finds Significant Increased Risk Of Bladder Cancer For SGLT2 Inhibitors With Empagliflozin (Posted by Tom Lamb at DrugInjuryWatch.com) For years there has been a lingering concern over whether Sodium-Glucose Co-Transporter-2…
-
Increased Risk Of Bladder Cancer Warning Added To Actos Label By Takeda Announced In August 2011
European Drug Regulator EMA Recommended New Actos Contra-Indications And Warnings In July 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: "European Medicines Agency clarifies opinion on pioglitazone and the risk of bladder cancer" …
-
Actos And Avandia Use Associated With Diabetic Macular Edema, Which Can Lead To Blindness
New UK Study Found Three To Six Times Increased Risk Of Developing This Retinal Eye Disease Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Avandia, Actos May Raise Risk of Macular Edema…
-
Actos-Related Bladder Cancer: June 2011 Review Of Regulatory Actions And Safety Warnings
FDA And Health Canada Warn About Increased Risk, While France And Germany Suspend Actos Sales (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines" (8/4/11)…